Bosh sahifa000100 ā¢ KRX
add
Yuhan Corp
Yopilish kursi
109Ā 800,00Ā ā©
Kunlik diapazon
106Ā 700,00Ā ā© - 110Ā 300,00Ā ā©
Yillik diapazon
68Ā 400,00Ā ā© - 166Ā 900,00Ā ā©
Bozor kapitalizatsiyasi
8,71Ā trln KRW
OŹ»rtacha hajm
459,75Ā ming
Narx/foyda
113,67
Dividend daromadliligi
0,47%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 496,10Ā mlrd | 13,49% |
Joriy xarajat | 158,12Ā mlrd | 25,16% |
Sof foyda | -11,51Ā mlrd | -113,43% |
Sof foyda marjasi | -2,32 | -111,84% |
Har bir ulushga tushum | -154,00 | -113,90% |
EBITDA | 4,68Ā mlrd | -73,81% |
Amaldagi soliq stavkasi | 45,58% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 330,70Ā mlrd | 2,70% |
Jami aktivlari | 2,94Ā trln | 4,61% |
Jami passivlari | 791,38Ā mlrd | 11,20% |
Umumiy kapital | 2,15Ā trln | ā |
Tarqatilgan aksiyalar | 75,00Ā mln | ā |
Narxi/balansdagi bahosi | 3,92 | ā |
Aktivlardan daromad | -1,01% | ā |
Kapitaldan daromad | -1,21% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -11,51Ā mlrd | -113,43% |
Operatsiyalardan naqd pul | 53,53Ā mlrd | -8,74% |
Sarmoyadan naqd pul | -19,08Ā mlrd | 65,62% |
Moliyadan naqd pul | 37,54Ā mlrd | 38,14% |
Naqd pulning sof oŹ»zgarishi | 76,62Ā mlrd | 192,15% |
BoŹ»sh pul | -3,16Ā mlrd | 85,62% |
Haqida
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
CEO
Tashkil etilgan
1926
Sayt
Xodimlar soni
1Ā 994
